- Home
- BMRN vs MAA Comparison
BMRN vs MAA Comparison
Compare BMRN & MAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | MAA |
|---|---|---|
| Founded | 1996 | 1977 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 13.6B |
| IPO Year | 1999 | 1995 |
Fundamental Metrics
Financial Performance| Metric | BMRN | MAA |
|---|---|---|
| Price | $56.74 | $117.17 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 28 | 26 |
| Target Price | $90.78 | ★ $133.60 |
| AVG Volume (30 Days) | ★ 2.4M | 918.1K |
| Earning Date | 11-02-2026 | 10-28-2026 |
| Dividend Yield | N/A | ★ 5.18% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.14 | ★ 1.06 |
| Revenue | $1,313,646,000.00 | ★ $2,209,126,000.00 |
| Revenue This Year | $20.05 | $0.90 |
| Revenue Next Year | $14.91 | $2.33 |
| P/E Ratio | $415.29 | ★ $111.50 |
| Revenue Growth | ★ 17.62 | 0.83 |
| 52 Week Low | $49.26 | $113.95 |
| 52 Week High | $70.98 | $144.41 |
Technical Indicators
Market Signals| Indicator | BMRN | MAA |
|---|---|---|
| Relative Strength Index (RSI) | 48.45 | 44.36 |
| Support Level | $53.19 | $114.93 |
| Resistance Level | $58.39 | $123.26 |
| Average True Range (ATR) | 1.85 | 2.35 |
| MACD | 0.33 | 0.05 |
| Stochastic Oscillator | 63.97 | 14.34 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About MAA Mid-America Apartment Communities Inc.
Mid-America Apartment Communities Inc is a multifamily-focused, self-administered and self-managed real estate investment trust. The company owns, operates, acquires and selectively develops apartment communities located in the Southeast, Southwest and Mid-Atlantic regions of the U.S. Its business objectives are to generate a sustainable, stable and increasing cash flow that will fund its dividends and distributions through all parts of the real estate investment cycle. It operates in two segments, Same Store and Non-Same Store and Other. The majority of the revenue is derived from Same Store segment.